Cart
sales@molnova.com
HS-10296
CAS No. 1899921-05-1
HS-10296( —— )
Catalog No. M20205 CAS No. 1899921-05-1
Hs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 186 | In Stock |
|
| 10MG | 295 | In Stock |
|
| 25MG | 498 | In Stock |
|
| 50MG | 716 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1998 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHS-10296
-
NoteResearch use only, not for human use.
-
Brief DescriptionHs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
-
DescriptionHs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
-
In VitroHS-10296 is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity, which canbe used to treat NSCLC. Additionaly, HS-10296 could also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR (E746_A750/T790M)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1899921-05-1
-
Formula Weight525.66
-
Molecular FormulaC30H35N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (190.24 mM);Ethanol:6 mg/mL (11.41 mM);Water:Insoluble
-
SMILESCOc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C2CC2)c2ccccc12
-
Chemical NameN-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
EMI1
EMI1 can be used in the mutant EGFR-associated, drug-resistant non-small-cell lung cancer(NSCLC) research. EMI1 is an inhibitor of EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S .
-
Vandetanib
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.
-
JCN037
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of 2.49 nM, 3.95 nM, 4.48 nM , respectively).
